search
Back to results

Prehabilitation in Patients With Cancer and Type 2 Diabetes

Primary Purpose

Cancer, Type 2 Diabetes

Status
Not yet recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Multimodal surgical prehabilitation
Sponsored by
University of Greenwich
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Cancer focused on measuring cancer, Type 2 diabetes, surgery, prehabilitation, recovery, exercise, nutrition, protein, anxiety, quality of life, physical performance

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Capacity to give consent
  • Newly diagnosed with cancer
  • Non-insulin-dependent Type 2 diabetes
  • Awaiting surgery for cancer

Exclusion Criteria:

  • Medical contraindication to engage in physical activity

Sites / Locations

  • School of Human Sciences, University of Greenwich, Avery Hill Campus, Sparrows Farm (Office SF112B)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Prehabilitation

Standard of care

Arm Description

Arm undergoing multimodal prehabilitation (physical activity, nutritional education and anxiety management) during the weeks leading up to surgery

Arm receiving standard of care (no prehabilitation)

Outcomes

Primary Outcome Measures

Changes in Short Physical Performance Battery (SPPB) at different time points from baseline to 1 year after surgery
Group of measures that combines the results of the gait speed, chair stand and balance tests, with scores ranging from 0 (worst performance) to 12 (best performance).

Secondary Outcome Measures

Changes in fasting glucose at different time points from baseline to 1 year after surgery
Blood fasting glucose obtained via finger prick
Changes in fasting insulin at different time points from baseline to 1 year after surgery
Blood fasting insulin obtained via finger prick
Changes in BMI at different time points from baseline to 1 year after surgery
Body mass index
Changes in waist circumference at different time points from baseline to 1 year after surgery
Waist circumference
Changes in hip circumference at different time points from baseline to 1 year after surgery
Hip circumferences
Changes in Patient Health Questionnaire-9 (PHQ-9) at different time points from baseline to 1 year after surgery
Self-administered questionnaires to assess depression severity, with scores ranging from 0 (no depression) to 27 (severe depression)

Full Information

First Posted
September 12, 2022
Last Updated
May 9, 2023
Sponsor
University of Greenwich
search

1. Study Identification

Unique Protocol Identification Number
NCT05547594
Brief Title
Prehabilitation in Patients With Cancer and Type 2 Diabetes
Official Title
Impact of a Multimodal Prehabilitation Programme on Markers of Health, Quality of Life and the Short and Long Post-surgery Recovery Period in Cancer Patients With Type 2 Diabetes
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 2023 (Anticipated)
Primary Completion Date
November 30, 2024 (Anticipated)
Study Completion Date
April 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Greenwich

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Surgical prehabilitation refers to pre-operative interventions aimed at increasing patients' physiological reserve so that they can better cope with the stress of surgery, avoid post-operative complications and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation. Although these aspects are well known, having a cancer diagnosis and the likelihood of an incoming operation during the weeks after diagnosis, place patients in a situation where they may be more receptive to adopting lifestyle changes aimed at promoting health. Such changes could be incorporated, not just in the short-term in preparation for surgery, but also in the medium- and long-term, improving patients' wellbeing and potentially reducing the risk of cancer reoccurrence and other diseases. Although the benefits of prehabilitation before surgery are understood, the effects it may have in non-insulin-dependent Type 2 diabetes patients are unknown. This project aims to: (i) Analyse the effects of a multimodal prehabilitation programme vs. the current National Health Service (NHS) standard approach, on physical performance in cancer patients with non-insulin-dependent Type 2 diabetes prior to surgery. (ii) Explore the impact of the programme on body composition and metabolic markers. (iii) Analyse the programme adherence, markers of well-being and quality of life during a post-surgery period of up to 12 months as well as its effects on clinical outcomes.
Detailed Description
This study will take advantage of already existing infrastructures, by approaching a single National Health Service (NHS) hospital in England that is already run a prehabilitation service for its patients. This study will analyse the effect of the prehabilitation programme on a specific group of patients, those with cancer and Type 2 diabetes who do not require insulin as part of their diabetes treatment and who are waiting for surgery. Surgical prehabilitation refers to interventions done before surgery to increase the patient's overall health and fitness so that they can better cope with the stress of surgery, avoid complications/reduce, and have a faster recovery after surgery. Multimodal prehabilitation combines different aspects related to a healthy lifestyle, including but not limited to; physical activity, nutritional education, anxiety coping strategies, alcohol moderation and smoking cessation. Multimodal prehabilitation programmes may use a combination of telehealth and face-to-face delivery to provide flexibility according to the preferences of the patients. The collaboration between the University of Greenwich and NHS will provide an opportunity to measure the impact of the programme on those participants with Type 2 diabetes, beyond variables like weight and fasting blood glucose (i.e., body composition, glycaemic behaviour, blood insulin concentration, immune system markers…). The hospital prehabilitation team will identify potential study participants (patients with Type 2 diabetes who do not use insulin awaiting surgery) amongst those referred to their service. The prehabilitation team will present the idea of the study to the potential participants and will ask for consent to share their contact details with the sponsor. If consent is received, the researcher will contact them to briefly present to them the possibility of joining the study. This 1st contact will be overseen by the Chief Investigator. Those who accept to participate in the study will be allocated into 2 different groups. Patients undergoing prehabilitation will join the prehabilitation group of the study, while those declining prehabilitation will join the control group. Regardless of the group, all patients will undergo the same number of interactions with the researcher: Interview and consent The candidate will be provided with the patient information sheet and explained what they can expect and what will be expected from them if they decide to participate in the study. Candidates will be able to ask questions and, in case they decide to participate, they will sign the participant consent form. Baseline/initial assessment The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers. This assessment will take place a few weeks before surgery before the patient starts prehabilitation (prehab group) or upon joining the study (control group). Assessment before surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers. This assessment will take place a few days before surgery. Assessment 6 weeks after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers. This assessment will take place 6 weeks after surgery, a time that generally allows the participant to recover enough to be able to move around comfortably and perform some light physical activity Assessment 6 months after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers. This assessment will take place 6 months after surgery, a time by which the patient will generally be fully recovered, potentially reaching their pre-surgical status, and will have been able to resume their regular day-to-day activity Assessment 12 months after surgery The participant will undergo a number of tests/measurements/questionnaires to obtain information on their physical performance quality of life, body composition, glycaemic markers and immune system markers. Both groups (prehabilitation and control) will undergo the same previously described assessments. This will allow us to understand and compare how the measured variables change through time in both groups (prehabilitation vs control). The investigators hypothesise that prehabilitation will improve patients' physical performance prior to surgery and will provide them with a range of tools to help them recover faster and manage their overall health better (including their diabetes control) for at least one year after surgery.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer, Type 2 Diabetes
Keywords
cancer, Type 2 diabetes, surgery, prehabilitation, recovery, exercise, nutrition, protein, anxiety, quality of life, physical performance

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Prehabilitation
Arm Type
Experimental
Arm Description
Arm undergoing multimodal prehabilitation (physical activity, nutritional education and anxiety management) during the weeks leading up to surgery
Arm Title
Standard of care
Arm Type
No Intervention
Arm Description
Arm receiving standard of care (no prehabilitation)
Intervention Type
Behavioral
Intervention Name(s)
Multimodal surgical prehabilitation
Intervention Description
Participants will be encouraged to engage in regular physical activity (endurance and resistance exercise), eat healthily and undergo cognitive behavioural therapy (the latter only if required) during the weeks prior to surgery.
Primary Outcome Measure Information:
Title
Changes in Short Physical Performance Battery (SPPB) at different time points from baseline to 1 year after surgery
Description
Group of measures that combines the results of the gait speed, chair stand and balance tests, with scores ranging from 0 (worst performance) to 12 (best performance).
Time Frame
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Secondary Outcome Measure Information:
Title
Changes in fasting glucose at different time points from baseline to 1 year after surgery
Description
Blood fasting glucose obtained via finger prick
Time Frame
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Title
Changes in fasting insulin at different time points from baseline to 1 year after surgery
Description
Blood fasting insulin obtained via finger prick
Time Frame
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Title
Changes in BMI at different time points from baseline to 1 year after surgery
Description
Body mass index
Time Frame
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Title
Changes in waist circumference at different time points from baseline to 1 year after surgery
Description
Waist circumference
Time Frame
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Title
Changes in hip circumference at different time points from baseline to 1 year after surgery
Description
Hip circumferences
Time Frame
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Title
Changes in Patient Health Questionnaire-9 (PHQ-9) at different time points from baseline to 1 year after surgery
Description
Self-administered questionnaires to assess depression severity, with scores ranging from 0 (no depression) to 27 (severe depression)
Time Frame
upon enrolment, before surgery, 6 weeks after surgery, 6 and 12 months after surgery
Other Pre-specified Outcome Measures:
Title
Hospital length of stay
Description
Number of days spent in the hospital after surgery
Time Frame
8 weeks after surgery
Title
90-day readmission
Description
Number of readmissions during the 90 days after surgery
Time Frame
90 days after surgery
Title
Postsurgical complications
Description
Number of complications after surgery
Time Frame
6 months after surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Capacity to give consent Newly diagnosed with cancer Non-insulin-dependent Type 2 diabetes Awaiting surgery for cancer Exclusion Criteria: Medical contraindication to engage in physical activity
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Fernando Naclerio, PhD
Phone
0044 2083 318441
Email
f.j.naclerio@greenwich.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Roberto Laza-Cagigas, MSc
Phone
0044 7597 058406
Email
r.lazacagigas@greenwich.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fernando Naclerio, PhD
Organizational Affiliation
University of Greenwich
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Human Sciences, University of Greenwich, Avery Hill Campus, Sparrows Farm (Office SF112B)
City
Eltham
State/Province
England
ZIP/Postal Code
SE9 2BT
Country
United Kingdom
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Fernando Naclerio, PhD
Phone
0044 2083 318441
Email
f.j.naclerio@greenwich.ac.uk
First Name & Middle Initial & Last Name & Degree
Roberto Laza-Cagigas, MSc
Phone
0044 7597 058406
Email
r.lazacagigas@greenwich.ac.uk
First Name & Middle Initial & Last Name & Degree
Ian Swaine, PhD
First Name & Middle Initial & Last Name & Degree
Marcos Seijo, PhD
First Name & Middle Initial & Last Name & Degree
Roberto Laza-Cagigas, PhD

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
34204531
Citation
Wu F, Rotimi O, Laza-Cagigas R, Rampal T. The Feasibility and Effects of a Telehealth-Delivered Home-Based Prehabilitation Program for Cancer Patients during the Pandemic. Curr Oncol. 2021 Jun 17;28(3):2248-2259. doi: 10.3390/curroncol28030207.
Results Reference
result

Learn more about this trial

Prehabilitation in Patients With Cancer and Type 2 Diabetes

We'll reach out to this number within 24 hrs